MAML2 _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10018448
Fusion event
HBV-MAML2 integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2017
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Start
1369
End
1688
Integrated sequence
GTTTCCATGGCTGCTAGGCTGTGCTGCCAACTGGATCCTGCGCGGGACGTCCTTTGTTTACGTCCCGTCGGCGCTGAATCCTGCGGACGACCCTTCTCGGGGTCGCTTGGGACTCTCTCGTCCCCTTCTCCGTCTGCCGTTCCGACCGACCACGGGGCGCACCTCTCTTTACGCGGACTCCCCGTCTGTGCCTTCTCATCTGCCGGACCGTGTGCACTTCGCTTCACCTCTGCACGTCGCATGGAGACCACCGTG
Host Sequence
Chromosome
chr11
Cytoband
q21
Reference genome
End
95978408/96245244 (Hg38)
Location type
Intron4
Target gene
Nearest miRNA
hsa-mir-10392/Upstream/1778664; hsa-let-7a-2/Downstream/96194;
Nearest cancer related gene
MAML2(OG, No orient, 0)
Upstream sequence
GGACATTTTCCACATCCACACCTTCTCTTCCTGCTTTGAGTATTTTAGAGGACTGTGCCTCGTAGTAAGAAAAAAATGAAACTCAGTTTCTTGAACCACA
Downstream sequence
TTTTGGAACATAAATTCTTTACATCAGGCTTTGTGCTAGAAATAGCTATTTGCAATGCTTTTTCCAGAATTTTTAATGAGTGTATCTCTAGTTTCTTTTA
Reference
Yoo, S., et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med ,2017, 15(1): 214.
Curate